Transparency | Takeda Ireland
Transparency
EFPIA Disclosure Code Reports
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. EFPIA believes that interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of patient treatment and the value of future research and therefore, requires transparency to these interactions through the EFPIA Disclosure Code. Country specific Industry Associations, in Ireland the Irish Pharmaceutical Healthcare Association (IPHA), transposed this Code into local Codes which went into effect on January 1, 2015.
Takeda supports the principles of transparency put forth by EFPIA and is committed to ensuring we meet the highest degree of integrity expected by our patients, healthcare professionals, healthcare organisations and other stakeholders.
Ireland Disclosure Reports are available on the IPHA Transfer of Value website.
Support for Patient Organisations
Patient Groups – or patient advocacy groups and patient organisations – are important partners for Takeda. Our aim is to forge trusting, mutually-beneficial relationships with patient groups. To build and maintain this trust, we are committed to understanding and addressing unmet needs in the patient community. We support patient organisations in our therapeutic areas through sponsorships, grants and donations.
In keeping with our commitment to ensure responsible business practices, Takeda believes transparency in our funding decisions is vital to building and maintaining trust with our stakeholders.
EXA/IE/CORP/0086 August 2025